|
US20040087498A1
(en)
*
|
1991-02-28 |
2004-05-06 |
Novo Nordisk Health Care Ag |
Modified factor VII
|
|
US6443974B1
(en)
*
|
1996-07-28 |
2002-09-03 |
Biosense, Inc. |
Electromagnetic cardiac biostimulation
|
|
US6099832A
(en)
*
|
1997-05-28 |
2000-08-08 |
Genzyme Corporation |
Transplants for myocardial scars
|
|
US6110459A
(en)
*
|
1997-05-28 |
2000-08-29 |
Mickle; Donald A. G. |
Transplants for myocardial scars and methods and cellular preparations
|
|
US6775574B1
(en)
*
|
1997-11-07 |
2004-08-10 |
Medtronic, Inc. |
Method and system for myocardial infarction repair
|
|
US7115417B1
(en)
|
1998-05-01 |
2006-10-03 |
Chancellor Michael B |
Soft tissue and bone augmentation and bulking utilizing muscle-derived progenito compositions, and treatments thereof
|
|
US6866842B1
(en)
|
1998-05-01 |
2005-03-15 |
University Of Pittsburgh |
Muscle-derived cells (MDCs) for treating muscle-or bone-related injury or dysfunction
|
|
DE69937888T2
(de)
*
|
1998-07-31 |
2009-01-02 |
Genzyme Corp., Cambridge |
Verfahren zur Herstellung mesenchymaler Stammzellen
|
|
AU5423300A
(en)
*
|
1999-06-25 |
2001-01-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Method of inducing angiogenesis by micro-organs
|
|
WO2001007568A2
(en)
*
|
1999-07-23 |
2001-02-01 |
Diacrin, Inc. |
Muscle cells and their use in cardiac repair
|
|
US20030113301A1
(en)
*
|
1999-07-23 |
2003-06-19 |
Albert Edge |
Muscle cells and their use in cardiac repair
|
|
DE10003521A1
(de)
*
|
2000-01-27 |
2001-08-09 |
Medigene Ag |
Vorrichtung zum Herstellen eines dreidimensionalen Matrixkörpers, Multi-Well-Platte, Lösung zum Kultivieren von Säugerkardiomyocyten, Verfahren zum Kultivieren einer Zellkultur, Vorrichtung für die Messung isometrischer Kraftparameter von Zellkulturen sowie Verfahren zum meßbaren Verfolgen von Kontraktionen eines in eine Trägersubstanz eingelagerten Zellgewebes
|
|
EP1272204B1
(en)
|
2000-04-14 |
2007-06-20 |
University of Pittsburgh |
Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
|
|
FR2810045B1
(fr)
*
|
2000-06-07 |
2004-09-03 |
Assist Publ Hopitaux De Paris |
Procede d'obtention de population cellulaires caracterisees d'origine musculaire et utilisations
|
|
US7862810B2
(en)
*
|
2000-07-31 |
2011-01-04 |
New York Medical College |
Methods and compositions for the repair and/or regeneration of damaged myocardium
|
|
AU2001284695A1
(en)
*
|
2000-07-31 |
2002-02-13 |
New York Medical College |
Methods and compositions for the repair and/or regeneration of damaged myocardium
|
|
US20110091428A1
(en)
*
|
2000-07-31 |
2011-04-21 |
New York Medical College |
Compositions of adult organ stem cells and uses thereof
|
|
US7547674B2
(en)
*
|
2001-06-06 |
2009-06-16 |
New York Medical College |
Methods and compositions for the repair and/or regeneration of damaged myocardium
|
|
US7491385B2
(en)
*
|
2001-09-05 |
2009-02-17 |
Genegrafts Ltd. |
Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
|
|
US7294333B1
(en)
|
2000-10-20 |
2007-11-13 |
Genegrafts Ltd. |
Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues
|
|
US6659995B1
(en)
*
|
2000-11-17 |
2003-12-09 |
Syde A. Taheri |
Autologous myocyte micro granual retrieval and implantation (AMMGRI)
|
|
DE10106512C1
(de)
*
|
2001-02-13 |
2002-05-23 |
Axel Haverich |
Verfahren zur Herstellung eines biologischen Gewebes unter Verwendung einer Kollagenunterlage und zugehöriges Gewebekonstrukt
|
|
US20020155096A1
(en)
|
2001-02-23 |
2002-10-24 |
Chancellor Michael B. |
Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
|
|
US7341062B2
(en)
*
|
2001-03-12 |
2008-03-11 |
Bioheart, Inc. |
Method of providing a dynamic cellular cardiac support
|
|
US7297538B2
(en)
*
|
2001-04-13 |
2007-11-20 |
Cardio3 S.A. |
Encapsulated cell indicator system
|
|
KR100694963B1
(ko)
*
|
2001-04-13 |
2007-03-14 |
(주)안트로젠 |
이식용 세포의 생산방법
|
|
US7993365B2
(en)
|
2001-06-08 |
2011-08-09 |
Morris Innovative, Inc. |
Method and apparatus for sealing access
|
|
US20070038244A1
(en)
*
|
2001-06-08 |
2007-02-15 |
Morris Edward J |
Method and apparatus for sealing access
|
|
JP4170897B2
(ja)
*
|
2001-06-08 |
2008-10-22 |
モリス イノヴェイティヴ リサーチ， インコーポレイテッド |
生体刺入口を封印するための方法および装置
|
|
GB2393734B
(en)
*
|
2001-07-12 |
2005-07-27 |
Geron Corp |
Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
|
|
US7732199B2
(en)
|
2001-07-12 |
2010-06-08 |
Geron Corporation |
Process for making transplantable cardiomyocytes from human embryonic stem cells
|
|
WO2003093433A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Regents Of The University Of Minnesota |
Fibrin-based biomatrix
|
|
US20040106896A1
(en)
*
|
2002-11-29 |
2004-06-03 |
The Regents Of The University Of California |
System and method for forming a non-ablative cardiac conduction block
|
|
US7361368B2
(en)
|
2002-06-28 |
2008-04-22 |
Advanced Cardiovascular Systems, Inc. |
Device and method for combining a treatment agent and a gel
|
|
AU2003259152A1
(en)
*
|
2002-07-23 |
2004-02-09 |
Boston Scientific Limited |
Cell therapy for regeneration
|
|
US20040191225A1
(en)
*
|
2002-08-06 |
2004-09-30 |
Dinsmore Jonathan H. |
Injection system
|
|
US7618948B2
(en)
|
2002-11-26 |
2009-11-17 |
Medtronic, Inc. |
Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA
|
|
US7829694B2
(en)
|
2002-11-26 |
2010-11-09 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
|
US7605249B2
(en)
|
2002-11-26 |
2009-10-20 |
Medtronic, Inc. |
Treatment of neurodegenerative disease through intracranial delivery of siRNA
|
|
US7627373B2
(en)
|
2002-11-30 |
2009-12-01 |
Cardiac Pacemakers, Inc. |
Method and apparatus for cell and electrical therapy of living tissue
|
|
US7994149B2
(en)
|
2003-02-03 |
2011-08-09 |
Medtronic, Inc. |
Method for treatment of Huntington's disease through intracranial delivery of sirna
|
|
US7732591B2
(en)
*
|
2003-11-25 |
2010-06-08 |
Medtronic, Inc. |
Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna
|
|
US8383158B2
(en)
|
2003-04-15 |
2013-02-26 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
CN103230415B
(zh)
|
2003-04-25 |
2016-05-04 |
匹兹堡大学联邦制高等教育 |
用于促进和增强神经修复和再生的肌肉来源的细胞（mdc）
|
|
WO2005072764A2
(en)
*
|
2004-01-16 |
2005-08-11 |
Novocell, Inc. |
Fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells
|
|
US7840263B2
(en)
|
2004-02-27 |
2010-11-23 |
Cardiac Pacemakers, Inc. |
Method and apparatus for device controlled gene expression
|
|
US20050208090A1
(en)
*
|
2004-03-18 |
2005-09-22 |
Medtronic, Inc. |
Methods and systems for treatment of neurological diseases of the central nervous system
|
|
US20050214938A1
(en)
*
|
2004-03-26 |
2005-09-29 |
Gold Joseph D |
Cardiac bodies: clusters of spontaneously contracting cells for regenerating cardiac function
|
|
US7452718B2
(en)
*
|
2004-03-26 |
2008-11-18 |
Geron Corporation |
Direct differentiation method for making cardiomyocytes from human embryonic stem cells
|
|
US7764995B2
(en)
*
|
2004-06-07 |
2010-07-27 |
Cardiac Pacemakers, Inc. |
Method and apparatus to modulate cellular regeneration post myocardial infarct
|
|
US8874204B2
(en)
*
|
2004-12-20 |
2014-10-28 |
Cardiac Pacemakers, Inc. |
Implantable medical devices comprising isolated extracellular matrix
|
|
US7981065B2
(en)
|
2004-12-20 |
2011-07-19 |
Cardiac Pacemakers, Inc. |
Lead electrode incorporating extracellular matrix
|
|
US20060134071A1
(en)
*
|
2004-12-20 |
2006-06-22 |
Jeffrey Ross |
Use of extracellular matrix and electrical therapy
|
|
US8060219B2
(en)
|
2004-12-20 |
2011-11-15 |
Cardiac Pacemakers, Inc. |
Epicardial patch including isolated extracellular matrix with pacing electrodes
|
|
US20060263338A1
(en)
*
|
2005-03-04 |
2006-11-23 |
Jacoby Douglas B |
Catheter-based delivery of Skeletal Myoblasts to the Myocardium of Damaged Hearts
|
|
JP4775663B2
(ja)
*
|
2005-03-30 |
2011-09-21 |
地方独立行政法人 大阪府立病院機構 |
血管新生制御方法
|
|
US20070059288A1
(en)
*
|
2005-03-31 |
2007-03-15 |
Dinsmore Jonathan H |
Treatment for heart disease
|
|
US8187621B2
(en)
|
2005-04-19 |
2012-05-29 |
Advanced Cardiovascular Systems, Inc. |
Methods and compositions for treating post-myocardial infarction damage
|
|
US8828433B2
(en)
|
2005-04-19 |
2014-09-09 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
|
US9539410B2
(en)
|
2005-04-19 |
2017-01-10 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating post-cardial infarction damage
|
|
US8303972B2
(en)
|
2005-04-19 |
2012-11-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
|
US20080125745A1
(en)
|
2005-04-19 |
2008-05-29 |
Shubhayu Basu |
Methods and compositions for treating post-cardial infarction damage
|
|
US20060253068A1
(en)
*
|
2005-04-20 |
2006-11-09 |
Van Bilsen Paul |
Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
|
|
EP1885854B1
(en)
*
|
2005-05-06 |
2012-10-17 |
Medtronic, Inc. |
Methods and sequences to suppress primate huntington gene expression
|
|
US7902352B2
(en)
*
|
2005-05-06 |
2011-03-08 |
Medtronic, Inc. |
Isolated nucleic acid duplex for reducing huntington gene expression
|
|
AU2006244197A1
(en)
*
|
2005-05-09 |
2006-11-16 |
Mytogen, Inc. |
Cellular cardiomyoplasty as supportive therapy in patients with heart disease
|
|
CN101228264B
(zh)
|
2005-06-22 |
2017-12-26 |
阿斯特利亚斯生物治疗股份公司 |
使灵长类多能干细胞分化成心肌细胞系细胞
|
|
US9133517B2
(en)
*
|
2005-06-28 |
2015-09-15 |
Medtronics, Inc. |
Methods and sequences to preferentially suppress expression of mutated huntingtin
|
|
US20080280843A1
(en)
*
|
2006-05-24 |
2008-11-13 |
Van Bilsen Paul |
Methods and kits for linking polymorphic sequences to expanded repeat mutations
|
|
US8038595B2
(en)
*
|
2006-01-25 |
2011-10-18 |
Beth Israel Deaconess Medical Center |
Devices and methods for tissue transplant and regeneration
|
|
WO2007092902A2
(en)
*
|
2006-02-07 |
2007-08-16 |
Organogenesis, Inc. |
Bioengineered tissue constructs and cardiac uses thereof
|
|
US9273356B2
(en)
|
2006-05-24 |
2016-03-01 |
Medtronic, Inc. |
Methods and kits for linking polymorphic sequences to expanded repeat mutations
|
|
US20080039415A1
(en)
*
|
2006-08-11 |
2008-02-14 |
Gregory Robert Stewart |
Retrograde transport of sirna and therapeutic uses to treat neurologic disorders
|
|
US9242005B1
(en)
|
2006-08-21 |
2016-01-26 |
Abbott Cardiovascular Systems Inc. |
Pro-healing agent formulation compositions, methods and treatments
|
|
WO2008027984A1
(en)
|
2006-08-29 |
2008-03-06 |
Isolagen Technologies, Inc. |
Methods for culturing minimally-passaged fibroblasts and uses thereof
|
|
WO2008033375A2
(en)
|
2006-09-14 |
2008-03-20 |
Medgenics Ltd. |
Long lasting drug formulations
|
|
US20080112927A1
(en)
*
|
2006-10-23 |
2008-05-15 |
Genegrafts Ltd. |
Cells and methods utilizing same for modifying the electrophysiological function of excitable tissues
|
|
US9375440B2
(en)
*
|
2006-11-03 |
2016-06-28 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
US9005672B2
(en)
|
2006-11-17 |
2015-04-14 |
Abbott Cardiovascular Systems Inc. |
Methods of modifying myocardial infarction expansion
|
|
US7988668B2
(en)
*
|
2006-11-21 |
2011-08-02 |
Medtronic, Inc. |
Microsyringe for pre-packaged delivery of pharmaceuticals
|
|
US7819842B2
(en)
*
|
2006-11-21 |
2010-10-26 |
Medtronic, Inc. |
Chronically implantable guide tube for repeated intermittent delivery of materials or fluids to targeted tissue sites
|
|
US7754486B2
(en)
*
|
2006-12-26 |
2010-07-13 |
Institut De Recherche En Hematologie Et Transplantation |
Culture medium named MV06 for both endothelial and myocardiac cells
|
|
US20100303770A1
(en)
*
|
2006-12-28 |
2010-12-02 |
John Maslowski |
Methods for culturing dermal cells for treatment of skin injuries such as burns
|
|
WO2008086040A1
(en)
|
2007-01-11 |
2008-07-17 |
University Of Pittsburgh |
Muscle derived cells for the treatment of urinary tract pathologies and methods of making and using the same
|
|
US20080171906A1
(en)
*
|
2007-01-16 |
2008-07-17 |
Everaerts Frank J L |
Tissue performance via hydrolysis and cross-linking
|
|
US9283302B2
(en)
*
|
2011-12-16 |
2016-03-15 |
Cormatrix Cardiovascular, Inc. |
Extracellular matrix encasement structures and methods
|
|
US9066993B2
(en)
*
|
2007-05-10 |
2015-06-30 |
Cormatrix Cardiovascular, Inc. |
Extracellular matrix encasement structures and methods
|
|
US20090024106A1
(en)
*
|
2007-07-17 |
2009-01-22 |
Morris Edward J |
Method and apparatus for maintaining access
|
|
US8247374B2
(en)
*
|
2007-11-09 |
2012-08-21 |
New York Medical College |
Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof
|
|
CN105400735A
(zh)
*
|
2008-01-30 |
2016-03-16 |
阿斯特利亚斯生物治疗股份公司 |
用于培养干细胞衍生的心肌细胞的合成表面
|
|
US8118832B1
(en)
|
2008-06-16 |
2012-02-21 |
Morris Innovative, Inc. |
Method and apparatus for sealing access
|
|
AU2009282619B2
(en)
|
2008-08-18 |
2015-08-20 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof
|
|
US8529883B2
(en)
|
2010-05-07 |
2013-09-10 |
Fibrocell Technologies, Inc. |
Dosage unit formulations of autologous dermal fibroblasts
|
|
WO2012038923A1
(en)
|
2010-09-22 |
2012-03-29 |
Centre Hospitalier Universitaire Vaudois |
Anti-fibrotic response provided by fetal cells to implants and delivery systems
|
|
WO2012051505A1
(en)
|
2010-10-14 |
2012-04-19 |
Fibrocell Science, Inc. |
Treatment of vocal cords with autologous dermal fibroblast formulation
|
|
WO2012111000A1
(en)
*
|
2011-02-14 |
2012-08-23 |
Technion Research And Development Foundation Ltd |
Tissue engineering construct comprising fibrin
|
|
EP3034087B1
(en)
|
2011-12-08 |
2018-03-14 |
Yeda Research and Development Co. Ltd. |
Mammalian fetal pulmonary cells and therapeutic use of same
|
|
AU2014277754B2
(en)
*
|
2012-09-24 |
2017-04-13 |
Cormatrix Cardiovascular, Inc. |
Extracellular matrix encasement structures and methods
|
|
US10668109B2
(en)
|
2015-06-18 |
2020-06-02 |
Yeda Research And Development Co. Ltd. |
Conditioning protocols and use of same for tissue regeneration
|
|
GB2546978B
(en)
*
|
2016-02-01 |
2019-01-23 |
Siemens Healthcare Gmbh |
Methods for visualising heart scar tissue
|
|
EP3778902A4
(en)
*
|
2018-03-30 |
2021-12-29 |
Kyoto University |
Cell production method
|
|
CN110358723A
(zh)
*
|
2019-05-08 |
2019-10-22 |
广州医科大学附属第二医院 |
一种成年小鼠心脏成纤维细胞的培养方法
|